$1.74
▼ -4.1% Today
as of Jul 23, 13:09 ET
Last 30 days
Recent Press Releases & News
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
Sunshine Biopharma Secures Approval for Generic Anastrozole in Canada
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
Overview
52-week range
$2.11
$24
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-21.1%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.25 | — | — | +43.2% | -37.1% | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.39 | — | — | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.44 | — | — | — | -5.0% | earnings |
| Sun Jun 30, 2024 | Jun 2024 | $-43.48 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-2.00 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | — | -$3.90 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | — | $9M | $9M | $9M | — | $8M | $9M |
| Cost of revenue | $6M | — | $6M | $6M | $6M | — | $6M | $7M |
| Gross profit | $2M | — | $3M | $3M | $3M | — | $3M | $2M |
| Operating income | $-1M | — | $-1M | $-2M | $-1M | — | $-1M | $-1M |
| Net income | $-1M | — | $-883,820 | $-2M | $-1M | — | $-1M | $-494,300 |
| EPS (diluted) | — | — | — | $-0.82 | $-0.44 | — | — | $-43.48 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Inventory | $13M | $13M | $14M | $13M | $12M | $11M | $10M | $8M |
| Total current assets | $25M | $27M | $28M | $28M | $24M | $26M | $26M | $26M |
| Total assets | $28M | $30M | $31M | $32M | $29M | $31M | $30M | $29M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $6M | $7M | $7M | $6M | $6M | $7M | $5M | $6M |
| Total equity | $22M | $23M | $24M | $26M | $23M | $24M | $25M | $23M |
Implied volatility — last 90 days
No IV snapshots yet for SBFM.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.